Table of Contents
Table 5-84: Vigo
Table 5-86: Warren
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 90 | 487.6 | 428 | 483.1 | 51 | 282.4 | 208 | 237.9 |
| Esophagus | * | # | 8 | 8.8** | * | # | 7 | 7.6** |
| Stomach | * | # | 3 | # | * | # | 3 | # |
| Colon excluding Rectum | 10 | 55.9** | 42 | 48.0 | 9 | 50.4** | 17 | 19.4** |
| Rectum and Rectosigmoid Junction | 8 | 41.2** | 21 | 23.2 | * | # | 4 | # |
| Liver | * | # | 3 | # | * | # | 2 | # |
| Pancreas | * | # | 7 | 7.8** | * | # | 9 | 10.4** |
| Lung and Bronchus | 12 | 65.3** | 79 | 88.8 | 15 | 81.8** | 66 | 74.9 |
| Melanoma of the Skin | * | # | 10 | 11.5** | * | # | 5 | 5.5** |
| Prostate | 21 | 113.6 | 102 | 113.2 | 6 | 33.4** | 23 | 27.5 |
| Urinary Bladder | 12 | 64.8** | 41 | 46.7 | * | # | 9 | 10.5** |
| Kidney and Renal Pelvis | * | # | 12 | 13.4** | * | # | 6 | 6.3** |
| Brain and Other Nervous System | * | # | 7 | 8.4** | * | # | 5 | 5.8** |
| Non-Hodgkin Lymphoma | * | # | 15 | 17.2** | * | # | 10 | 11.9** |
| Myeloma | * | # | 5 | 5.9** | * | # | 3 | # |
| Leukemia | * | # | 16 | 17.9** | * | # | 13 | 15.2** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 61 | 254.2 | 437 | 384.4 | 33 | 136.4 | 212 | 172.2 |
| Colon excluding Rectum | 8 | 24.0** | 52 | 41.0 | 5 | 20.9** | 23 | 19.2 |
| Rectum and Rectosigmoid Junction | * | # | 15 | 12.6** | * | # | 5 | 3.5** |
| Liver | * | # | 1 | # | * | # | 3 | # |
| Pancreas | * | # | 7 | 5.5** | * | # | 8 | 6.1** |
| Lung and Bronchus | 8 | 36.7** | 61 | 52.1 | 6 | 23.7** | 57 | 46.3 |
| Melanoma of the Skin | * | # | 14 | 14.9** | * | # | 2 | # |
| Breast | 25 | 105.6 | 134 | 121.0 | 7 | 33.9** | 33 | 27.3 |
| Cervix Uteri | * | # | 6 | 7.2** | * | # | 1 | # |
| Corpus Uteri | * | # | 20 | 18.3 | * | # | 2 | # |
| Ovary | * | # | 13 | 11.3** | * | # | 20 | 16.3 |
| Urinary Bladder | * | # | 18 | 13.9** | * | # | 5 | 3.1** |
| Kidney and Renal Pelvis | * | # | 10 | 10.1** | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 7 | 6.2** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 20 | 17.0 | * | # | 10 | 8.6** |
| Myeloma | * | # | 6 | 5.2** | * | # | 3 | # |
| Leukemia | * | # | 5 | 4.1** | * | # | 5 | 4.0** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-84: Vigo
Table 5-86: Warren
